Vanta Bioscience Share Price
17 Nov, 2026 4:01 PM (IST)
Vanta Bioscience Performance
- Today's Low
- ₹17
- Today's High
- ₹18
- 52 Week Low
- ₹15
- 52 Week High
- ₹26
- Open Price₹18
- Previous Close₹19
- Volume2,250
- 50 DMA₹21.00
- 100 DMA₹21.60
- 200 DMA₹25.40
Vanta Bioscience Chart
Investment Returns
- Over 1 Month -11.76%
- Over 3 Month -8.35%
- Over 6 Month + 5.82%
- Over 1 Year -31.35%
Smart Investing Starts Here Start SIP with Vanta Bioscience for Steady Growth!
Vanta Bioscience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 118.2
- PEG Ratio
- -
- Market Cap Cr
- 13
- P/B Ratio
- 0.6
- Average True Range
- 1.3
- EPS
- 0.2
- Dividend Yield
- 0
- MACD Signal
- -0.7
- RSI
- 36.47
- MFI
- 16.69
Latest Stock News Updates
Outcome of Board Meeting
- BSE India
- 6 days 1 hour ago
Outcome of Board Meeting
- BSE India
- 6 days 1 hour ago
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting scheduled to be held on Friday, November 13, 2026 at 06:00 PM at the registered office of the Company, inter-alia, to consider and approve the Standalone and Consolidated unaudited Financial Results of the Company for the half year ended September 30, 2026 Intimation of Board Meeting scheduled to be held on Friday, November 13, 2026 at 06:00 PM at the registered office of the Company, inter-alia, to consider and approve the Standalone and Consolidated unaudited Financial Results of the Company for the half year ended September 30, 2026
- BSE India
- 1 week 3 days ago
Vanta Bioscience Financials
Vanta Bioscience Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹20.60
- 50 Day
- ₹21.00
- 100 Day
- ₹21.60
- 200 Day
- ₹25.40
Resistance and Support
- R3 19.80
- R2 18.90
- R1 18.40
- S1 17.10
- S2 16.20
- S3 15.80
Vanta Bioscience Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-13 | Half Yearly Results | |
| 2026-05-30 | Audited Results | |
| 2025-11-14 | Half Yearly Results | |
| 2025-08-01 | Audited Results | (Revised) |
| 2024-12-06 | Increase in Authorised Capital | Inter alia, to consider : (1) Conversion of unsecured loans from Promoters and others into equity shares and increase in the authorized capital as per requirement |
About Vanta Bioscience
Vanta Bioscience presently engaged in the business of Preclinical Activities. View More- NSE Symbol
- VANTABIO
- BSE Symbol
- 540729
- ISIN
- INE695X01011
Similar Stocks to Vanta Bioscience
Popular Stocks
Vanta Bioscience FAQs
Vanta Bioscience share price is ₹18 As on 19 November, 2026 | 19:56
The Market Cap of Vanta Bioscience is ₹12.8 Cr As on 19 November, 2026 | 19:56
The P/E ratio of Vanta Bioscience is 118.2 As on 19 November, 2026 | 19:56
The PB ratio of Vanta Bioscience is 0.6 As on 19 November, 2026 | 19:56
The 52 week High & Low of Vanta Bioscience is ₹25.8/₹14.7 respectively As on 19 November, 2026 | 19:56
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.